Top Markets
#1 Purr Purr +53.84%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 龙虾 (Lobster) 龙虾 (Lobster) +23.47%
#4 Pons Pons +23.13%
#5 Non-Playable Coin Non-Playable Coin +20.70%
#6 OriginTrail OriginTrail +19.75%
#7 ApeX ApeX +18.50%
#8 Morpho Morpho +17.90%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.62%
#10 Zora Zora +17.49%
Coin of the day
Purr Purr
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
Hisse Senetlerindeki Sıralama #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
Hisse Fiyatı
$0.84903405
Son senkronizasyon: 2026-07-27
Piyasa Değeri
$106.63M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
38.69%
Ülke
TW
Ticaret Genovate Biotechnology Co., Ltd. (4130)

Kategori

Healthcare
Genovate Biotechnology Co., Ltd. (4130) için kazanç
2026 itibarıyla kazanç TTM: 0
Genovate Biotechnology Co., Ltd. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Genovate Biotechnology Co., Ltd. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH